These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32695243)

  • 1. Expression and Significance of Insulin Receptor Substrate 1 in Human Hepatocellular Carcinoma.
    Gao C; Zhang H; Zhang WS; Fang L
    Dis Markers; 2020; 2020():7174062. PubMed ID: 32695243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study.
    Wang Z; Gou W; Liu M; Sang W; Chu H; Zhang W
    Med Sci Monit; 2015 Oct; 21():3209-15. PubMed ID: 26494212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
    Mondal G; Saroha A; Bose PP; Chatterjee BP
    Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Kwon SH; Jeong SW; Jang JY; Lee JE; Lee SH; Kim SG; Kim YS; Cho YD; Kim HS; Kim BS; Jin SY
    Clin Mol Hepatol; 2012 Sep; 18(3):287-94. PubMed ID: 23091809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of hsa_circ_0003570 in hepatocellular carcinoma and its clinical significance.
    Fu L; Wu S; Yao T; Chen Q; Xie Y; Ying S; Chen Z; Xiao B; Hu Y
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28493512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma.
    Park BC; Huh MH; Seo JH
    J Hepatol; 1995 Mar; 22(3):286-94. PubMed ID: 7608479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma.
    Harada K; Shiota G; Kawasaki H
    Liver; 1999 Aug; 19(4):318-25. PubMed ID: 10459631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1-mediated inflammation and growth activated & inhibited transition mechanisms between no-tumor hepatitis/cirrhotic tissues and HCC.
    Diao H; Wang L; Huang J; Jiang M; Zhou H; Li X; Chen Q; Jiang Z; Feng H
    J Cell Biochem; 2014 Apr; 115(4):641-50. PubMed ID: 24151232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
    Xie Y; Yao Q; Butt AM; Guo J; Tian Z; Bao X; Li H; Meng Q; Lu J
    Cancer Biol Ther; 2014 Sep; 15(9):1248-55. PubMed ID: 24971953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma.
    El-Bassiouni NE; Nosseir MM; Madkour ME; Zoheiry MM; Bekheit IW; Ibrahim RA; Ibrahim IM; El Bassiouny AE
    Mol Biol Rep; 2012 Jun; 39(6):6843-50. PubMed ID: 22318548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and significance of microRNA-183 in hepatocellular carcinoma.
    Liang Z; Gao Y; Shi W; Zhai D; Li S; Jing L; Guo H; Liu T; Wang Y; Du Z
    ScientificWorldJournal; 2013; 2013():381874. PubMed ID: 24222732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
    World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.
    Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ
    Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma.
    Seo JH; Park BC
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions.
    Reis H; Bertram S; Pott L; Canbay A; Gallinat A; Baba HA
    Pathol Oncol Res; 2017 Jan; 23(1):33-39. PubMed ID: 27276915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis.
    Miyakawa H; Izumi N; Marumo F; Sato C
    Alcohol Clin Exp Res; 1996 Feb; 20(1 Suppl):91A-94A. PubMed ID: 8659700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of pro-apoptotic Bid level in chronic hepatitis, hepatocellular carcinoma and liver metastases.
    Chen GG; Lai PB; Chak EC; Xu H; Lee KM; Lau WY
    Cancer Lett; 2001 Oct; 172(1):75-82. PubMed ID: 11595132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease.
    Yusof YA; Yan KL; Hussain SN
    Anal Quant Cytol Histol; 2003 Dec; 25(6):332-8. PubMed ID: 14714299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis.
    Wang D; Zhang X; Lu Y; Wang X; Zhu L
    Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.